| scholarly article | Q13442814 |
| P2093 | author name string | Dan Călugăru | |
| Mihai Călugăru | |||
| P2860 | cites work | Ranibizumab in preproliferative (ischemic) central retinal vein occlusion: the rubeosis anti-VEGF (RAVE) trial | Q88049292 |
| Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex) in its treatment | Q88068855 | ||
| Ocular hypertension in patients with central/hemicentral retinal vein occlusions: cumulative prevalence and management | Q90479166 | ||
| Central retinal vein occlusion case-control study | Q28222454 | ||
| Blood flow of the optic nerve head and peripapillary retina in exfoliation syndrome with unilateral glaucoma or ocular hypertension | Q30994661 | ||
| Predictors of long-term progression in the early manifest glaucoma trial | Q33290742 | ||
| Ocular hypertension: an approach to assessment and management | Q35460478 | ||
| A longitudinal analysis of risk factors associated with central retinal vein occlusion | Q36586154 | ||
| Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma | Q38367081 | ||
| The 10-year incidence and risk factors of retinal vein occlusion: the Beijing eye study | Q39478622 | ||
| Central retinal vein occlusion risk profile: a case-control study | Q39653833 | ||
| Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. | Q42594632 | ||
| Comparison of Travoprost and Bimatoprost plus timolol fixed combinations in open-angle glaucoma patients previously treated with latanoprost plus timolol fixed combination | Q42945175 | ||
| Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma | Q43267965 | ||
| Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma | Q43623919 | ||
| Cup-to-disc ratio, intraocular pressure, and primary open-angle glaucoma in retinal venous occlusion | Q43875349 | ||
| Measuring visual field progression in the Early Manifest Glaucoma Trial | Q44461417 | ||
| Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion | Q44719142 | ||
| The relationship of optic disk cupping to retinal vein occlusion: the Beaver Dam Eye Study | Q46982990 | ||
| Intravitreal bevacizumab in acute central/hemicentral retinal vein occlusions: three-year results of a prospective clinical study. | Q51042998 | ||
| Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group | Q71054248 | ||
| The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group | Q77436650 | ||
| The treatment of normal-tension glaucoma | Q77436667 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 436-441 | |
| P577 | publication date | 2019-01-01 | |
| P1433 | published in | International Journal of Ophthalmology | Q26841911 |
| P1476 | title | Management of the open angle glaucoma in patients with central/hemicentral retinal vein occlusions | |
| P478 | volume | 12 |
Search more.